search

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

ABOUT US

图片名称

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company


Release time:

2021-08-02

Qilu Pharmaceutical was awarded as The Best R&D Pipeline Pharmaceutical Company in the 38th Pharmaceutical Industry Information Annual Conference.

To date, Qilu has launched 300+ products with 47 products “first to launch or exclusive launch in China. Qilu has currently 60 innovative projects in the pipeline, and among them, 10+ innovative projects are in clinical stage and one innovative product will be launched in 2022.

With drugs exported to more than 80 countries and regions, Qilu Pharmaceutical marks the only domestic pharmaceutical company that exports FDF to all the main regulated markets, covering Europe, USA, UK, Japan and Australia, among which 18 of our products enjoy the largest market share. In addition, Qilu Pharmaceutical acts as the pioneer in the exportation of injectable products with commercial package to Japan. To date, 16 FDFs have been marketed in the USA and 10 in Europe. 12 APIs for human use from Qilu Pharmaceutical enjoy the world’s largest market share, including the families of Cephalosporin and Tazobactam.

齐鲁制药有限公司
齐鲁制药有限公司
齐鲁制药有限公司

 

Tel: +86-531-83127705831277048312770683127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

Email:export@qilu-pharma.com


监督举报

亲爱的合作伙伴:

欢迎举报以下行为!

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话:0531-83126898/55820713/83126871

举报邮箱:qljc@qilu-pharma.com

收信地址:山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线